Provention Bio Inc buy Chardan Capital
Start price
13.03.23
/
50%
€22.41
Target price
13.03.24
€23.30
Performance (%)
1.07%
End price
14.03.24
-
Summary
This prediction is currently being closed. The BUY prediction by Chardan_Capital shows slight gains of 1.07%. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Provention Bio Inc | - | - | - | - |
| iShares Core DAX® | 2,49 % | -5,94 % | 2,90 % | 45,72 % |
| iShares Nasdaq 100 | 1,65 % | -2,46 % | 15,75 % | 73,26 % |
| iShares Nikkei 225® | 0,55 % | -7,60 % | 30,35 % | 48,77 % |
| iShares S&P 500 | 1,35 % | -2,94 % | 10,34 % | 55,80 % |
Comments by Chardan_Capital for this prediction
In the thread Provention Bio Inc diskutieren
Provention Bio, Inc. (NASDAQ: PRVB) had its price target lowered by analysts at Chardan Capital from $30.00 to $25.00. They now have a "buy" rating on the stock.
Ratings data for PRVB provided by MarketBeat
In the thread Trading Provention Bio Inc
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten